Literature DB >> 11432979

Induction of NADPH cytochrome P450 reductase by the Alzheimer beta-protein. Amyloid as a "foreign body".

M A Pappolla1, R A Omar, Y J Chyan, J Ghiso, K Hsiao, P Bozner, G Perry, M A Smith, F Cruz-Sanchez.   

Abstract

A large body of data suggests that the Alzheimer's amyloid peptide (Abeta) causes degeneration and death of neurons by mechanisms that involve reactive oxygen species. The pathways involved in Abeta-mediated oxidative injury are only partially understood. We theorized that abnormal microaggregates and/or pathological conformations of Abeta peptides may behave as xenobiotics and trigger the induction of NADPH cytochrome P450 reductase (CP450r), an enzyme which, if induced by non-physiological substrates (such as xenobiotics like drugs or other 'foreign molecules'), is known to cause oxidative stress. In order to test this hypothesis, i.e. that Abeta can increase the expression of CP450r, SK-N-SH human neuroblastoma cells were exposed to Abeta25-35 and Abeta1-42 and then examined for induction of this enzyme in immunoblots, using specific antibodies. Following exposure to Abeta peptides, neuroblastoma cells showed a clear-cut induction of CP450r. To determine whether this mechanism is operational in vivo, we investigated the expression of CP450r in a transgenic mouse model of Alzheimer's disease (AD) and in brains from patients afflicted with AD, using an immunocytochemical approach. Tissue sections from brains of transgenic mice exhibited strong immunoreactivity for CP450r, surrounding amyloid deposits. The pattern of expression of CP450r was similar to that exhibited by neuritic and oxidative stress markers. Sections from non-transgenic mice showed no detectable immunoreactivity. Immunostaining of sections from four brains with neuropathologically confirmed AD showed a pattern of abnormality different from transgenic mice that was characterized by abnormal immunoreactivity for CP450r within the cytoplasm of cortical neurons. No labeling was seen in sections from aged-matched control brains. The data showed that CP450r is induced by Alzheimer amyloid peptide and that such a response must be considered as one possible mechanism whereby Abeta causes oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11432979     DOI: 10.1046/j.1471-4159.2001.00379.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  6 in total

Review 1.  Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution.

Authors:  Massimo Stefani; Christopher M Dobson
Journal:  J Mol Med (Berl)       Date:  2003-08-27       Impact factor: 4.599

2.  Suppression of cytochrome P450 reductase expression promotes astrocytosis in subventricular zone of adult mice.

Authors:  Yunyi Yao; Senyan Liu; Yue Wang; Weiping Yuan; Xinxin Ding; Tao Cheng; Qin Shen; Jun Gu
Journal:  Neurosci Lett       Date:  2013-05-30       Impact factor: 3.046

3.  Microarray analysis of hepatic gene expression in gallstone-susceptible and gallstone-resistant mice.

Authors:  Patricia A Dyck; Farzana Hoda; Elizabeth S Osmer; Richard M Green
Journal:  Mamm Genome       Date:  2003-09       Impact factor: 2.957

4.  Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease.

Authors:  Fiona Kerr; Oyinkan Sofola-Adesakin; Dobril K Ivanov; Jemma Gatliff; Beatriz Gomez Perez-Nievas; Hélène C Bertrand; Pedro Martinez; Rebecca Callard; Inge Snoeren; Helena M Cochemé; Jennifer Adcott; Mobina Khericha; Jorge Iván Castillo-Quan; Geoffrey Wells; Wendy Noble; Janet Thornton; Linda Partridge
Journal:  PLoS Genet       Date:  2017-03-02       Impact factor: 5.917

Review 5.  Protein folding and aggregation into amyloid: the interference by natural phenolic compounds.

Authors:  Massimo Stefani; Stefania Rigacci
Journal:  Int J Mol Sci       Date:  2013-06-13       Impact factor: 5.923

6.  CYP2C19 variant mitigates Alzheimer disease pathophysiology in vivo and postmortem.

Authors:  Andréa L Benedet; Lei Yu; Aurélie Labbe; Sulantha Mathotaarachchi; Tharick A Pascoal; Monica Shin; Min-Su Kang; Serge Gauthier; Guy A Rouleau; Judes Poirier; David A Bennett; Pedro Rosa-Neto
Journal:  Neurol Genet       Date:  2018-01-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.